HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 202 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q3 2023. The put-call ratio across all filers is 0.36 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $614,000 | +47.2% | 18,706 | +58.0% | 0.00% | – |
| Q2 2023 | $417,000 | +64.2% | 11,837 | +52.3% | 0.00% | – |
| Q1 2023 | $254,000 | -56.0% | 7,774 | -25.8% | 0.00% | – |
| Q4 2022 | $577,000 | +124.5% | 10,479 | +80.7% | 0.00% | – |
| Q3 2022 | $257,000 | +542.5% | 5,800 | +609.9% | 0.00% | – |
| Q2 2022 | $40,000 | -63.3% | 817 | -63.6% | 0.00% | – |
| Q1 2022 | $109,000 | -47.1% | 2,242 | -53.7% | 0.00% | – |
| Q4 2021 | $206,000 | +64.8% | 4,843 | +48.7% | 0.00% | – |
| Q3 2021 | $125,000 | +92.3% | 3,257 | +42.0% | 0.00% | – |
| Q2 2021 | $65,000 | +195.5% | 2,293 | +242.2% | 0.00% | – |
| Q1 2021 | $22,000 | +1000.0% | 670 | +1096.4% | 0.00% | – |
| Q4 2020 | $2,000 | – | 56 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |